Antimicrobial peptides in periodontal innate defense

Frontiers of Oral Biology

Volumn 15, Issue , 2012, Pages 84-98

  Gorr, Sven Ulrik ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL TOXIN; BIOLOGICAL MARKER; BPIFA2 PROTEIN, HUMAN; LEUKOCYTE ELASTASE INHIBITOR; SALIVA PROTEIN;

ANTIGEN PRESENTING CELL; BIOFILM; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION PROFILING; GINGIVITIS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; MOUTH MUCOSA; NEUTROPHIL; PERIODONTAL DISEASE; PHYSIOLOGY; REVIEW;

ANTIGEN-PRESENTING CELLS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL TOXINS; BIOFILMS; BIOLOGICAL MARKERS; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GINGIVAL CREVICULAR FLUID; HUMANS; IMMUNITY, INNATE; MOUTH MUCOSA; NEUTROPHILS; PERIODONTAL DISEASES; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SALIVARY PROTEINS AND PEPTIDES;

EID: 84855522617     PISSN: 14202433     EISSN: 16623770     Source Type: Book Series    
DOI: 10.1159/000329673     Document Type: Article

References (101)

1. Morris AJ, Steele J, White DA: The oral cleanliness and periodontal health of UK adults in 1998. Br Dent J 2001;191:186-192. (Pubitemid 33755285)
2. Kig J, Holtfreter B, Kocher T: Periodontal health in Europe: future trends based on treatment needs and the provision of periodontal services -position paper 1. Eur J Dent Educ 2010;14:4-24.
3. Paster BJ, Olsen I, Aas JA, Dewhirst FE: The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 2006; 42:80-87.
4. Periodontics WWoC: Consensus report. Periodontal diseases: pathogenesis and microbial factors. Ann Periodontol 1996;1:926-932.
5. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr: Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144. (Pubitemid 128705944)
6. Teles RP, Haffajee AD, Socransky SS: Microbiological goals of periodontal therapy. Periodontol 2000 2006; 42:180-218.
7. Lovegrove JM: Dental plaque revisited: Bacteria associated with periodontal disease. J N Z Soc Periodontol 2004:7-21. (Pubitemid 38707464)
8. Van Dyke TE: Control of inflammation and periodontitis. Periodontology 2000 2007;45:158-166.
9. Denny P, Hagen FK, Hardt M, Liao L, Yan W, Arellanno M, Bassilian S, Bedi GS, Boontheung P, Cociorva D, Delahunty CM, Denny T, Dunsmore J, Faull KF, Gilligan J, Gonzalez-Begne M, Halgand F, Hall SC, Han X, Henson B, Hewel J, Hu S, Jeffrey S, Jiang J, Loo JA, Ogorzalek Loo RR, Malamud D, Melvin JE, Miroshnychenko O, Navazesh M, Niles R, Park SK, Prakobphol A, Ramachandran P, Richert M, Robinson S, Sondej M, Souda P, Sullivan MA, Takashima J, Than S, Wang J, Whitelegge JP, Witkowska HE, Wolinsky L, Xie Y, Xu T, Yu W, Ytterberg J, Wong DT, Yates JR, Fisher SJ: The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res 2008;7:1994-2006.
10. Gorr S-U: Antimicrobial peptides of the oral cavity. Periodontol 2000 2009;51:152-180.
11. Putsep K, Carlsson G, Boman HG, Andersson M: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002;360:1144-1149. (Pubitemid 35246490)
12. de Haar SF, Hiemstra PS, van Steenbergen MTJM, Everts V, Beertsen W: Role of polymorphonuclear leukocyte-derived serine proteinases in defense against actinobacillus actinomycetemcomitans. Infect Immun 2006;74:5284-5291. (Pubitemid 44300447)
13. Hart TC, Hart PS, Michalec MD, Zhang Y, Firatli E, Van Dyke TE, Stabholz A, Zlotogorski A, Shapira L, Soskolne WA: Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C. J Med Genet 2000;37:88-94. (Pubitemid 30245890)
14. Loe H, Theilade E, Jensen SB: Experimental gingivitis in man. J Periodontol 1965;36:177-187.
15. Baumgartner S, Imfeld T, Schicht O, Rath C, Persson RE, Persson GR: The impact of the stone age diet on gingival conditions in the absence of oral hygiene. J Periodontol 2009;80:759-768.
16. Gorr SU, Abdolhosseini M: Antimicrobial peptides and periodontal disease. J Clin Periodontol 2011;38: 126-141.
17. Hosokawa I, Hosokawa Y, Komatsuzawa H, Goncalves RB, Karimbux N, Napimoga MH, Seki M, Ouhara K, Sugai M, Taubman MA, Kawai T: Innate immune peptide ll-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clin Exp Immunol 2006;146:218-225. (Pubitemid 44581336)
18. Diamond G, Beckloff N, Weinberg A, Kisich KO: The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 2009;15:2377-2392.
19. Yang D, Oppenheim JJ: Alarmins and antimicrobial immunity. Med Mycol 2009;47:S146-S153.
20. Soehnlein O: Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins. J Mol Med 2009;87:1157-1164.
21. Kai-Larsen Y, Agerberth B: The role of the multifunctional peptide ll-37 in host defense. Front Biosci 2008;13:3760-3767. (Pubitemid 351594656)
22. Bachrach G, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, Merrick J, Chaushu S: Salivary ll-37 secretion in individuals with down syndrome is normal. J Dent Res 2006;85:933-936. (Pubitemid 44578606)
23. Tao R, Jurevic RJ, Coulton KK, Tsutsui MT, Roberts MC, Kimball JR, Wells N, Berndt J, Dale BA: Salivary antimicrobial peptide expression and dental caries experience in children. Antimicrob Agents Chemother 2005;49:3883-3888. (Pubitemid 41233045)
24. Puklo M, Guentsch A, Hiemstra PS, Eick S, Potempa J: Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin ll-37 in the innate immune response against periodontogenic bacteria. Oral Microbiol Immunol 2008;23:328-335. (Pubitemid 351832179)
25. Turkoglu O, Emingil G, Kutukculer N, Atilla G: Gingival crevicular fluid levels of cathelicidin ll-37 and interleukin-18 in patients with chronic periodontitis. J Periodontol 2009;80:969-976.
26. Dommisch H, Vorderwbecke S, Eberhard J, Steglich M, Jepsen S: SELDI-TOF-MS of gingival crevicular fluid -a methodological approach. Arch Oral Biol 2009;54:803-809.
27. Tanaka D, Miyasaki KT, Lehrer RI: Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol Immunol 2000;15: 226-231. (Pubitemid 30466488)
28. Dorschner RA, Lopez-Garcia B, Peschel A, Kraus D, Morikawa K, Nizet V, Gallo RL: The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J 2006;20: 35-42. (Pubitemid 43100473)
29. Ji S, Hyun J, Park E, Lee BL, Kim KK, Choi Y: Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res 2007;42:410-419.
30. Gutner M, Chaushu S, Balter D, Bachrach G: Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of porphyromonas gingivalis. Infect Immun 2009;77:5558-5563.
31. Yang D, Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O: LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000;192:1069-1074.
32. Wu WKK, Wang G, Coffelt SB, Betancourt AM, Lee CW, Fan D, Wu K, Yu J, Sung JJY, Cho CH: Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int J Cancer 2010;127:1741-1747.
33. von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, Bals R: The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer 2008;59:12-23.
34. Tai EKK, Wu WKK, Wong HPS, Lam EKY, Yu L, Cho CH: A new role for cathelicidin in ulcerative colitis in mice. Exp Biol Med 2007;232:799-808. (Pubitemid 46827822)
35. Tai EKK, Wong HPS, Lam EKY, Wu WKK, Yu L, Koo MWL, Cho CH: Cathelicidin stimulates colonic mucus synthesis by up-regulating MUC1 and MUC2 expression through a mitogen-activated protein kinase pathway. J Cell Biochem 2008; 104: 251-258.
36. Bucki R, Namiot DB, Namiot Z, Savage PB, Janmey PA: Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 2008;62:329-225.
37. Larrick JW, Hirata M, Balint RF, Lee J, Zhong J, Wright SC: Human cap18: a novel antimicrobial lipopolysaccharide-binding protein. Infect Immun 1995;63:1291-1297.
38. Inomata M, Into T, Murakami Y: Suppressive effect of the antimicrobial peptide LL-37 on expression of IL-6, IL-8 and CXCL10 induced by Porphyromonas gingivalis cells and extracts in human gingival fibroblasts. Eur J Oral Sci 2010;118:574-581.
39. Ganz T: Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3:710-720. (Pubitemid 41070812)
40. Lundy FT, Nelson J, Lockhart D, Greer B, Harriott P, Marley JJ: Antimicrobial activity of truncated [alpha]-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges. Mol Immunol 2008;45:190-193. (Pubitemid 47331643)
41. Raj PA, Antonyraj KJ, Karunakaran T: Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem J 2000;347(part 3):633-641. (Pubitemid 30260951)
42. Miyasaki KT, Bodeau AL, Ganz T, Selsted ME, Lehrer RI: In vitro sensitivity of oral, gram-negative, facultative bacteria to the bactericidal activity of human neutrophil defensins. Infect Immun 1990;58: 3934-3940.
43. Niyonsaba F, Iwabuchi K, Matsuda H, Ogawa H, Nagaoka I: Epithelial cell-derived human β-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase c-dependent pathway. Int Immunol 2002;14: 421-426. (Pubitemid 34257769)
44. Lee SH, Jun HK, Lee HR, Chung CP, Choi BK: Antibacterial and lipopolysaccharide (LPS)-neutralising activity of human cationic antimicrobial peptides against periodontopathogens. Int J Antimicrob Agents 2010;35:138-145.
45. Vankeerberghen A, Nuytten H, Dierickx K, Quirynen M, Cassiman JJ, Cuppens H: Differential induction of human beta-defensin expression by periodontal commensals and pathogens in periodontal pocket epithelial cells. J Periodontol 2005; 76:1293-1303. (Pubitemid 41245773)
46. Michalowicz BS, Diehl SR, Gunsolley JC, Sparks BS, Brooks CN, Koertge TE, Califano JV, Burmeister JA, Schenkein HA: Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol 2000;71:1699-1707.
47. Schaefer AS, Richter GM, Nothnagel M, Laine ML, Ruhling A, Schafer C, Cordes N, Noack B, Folwaczny M, Glas J, Dorfer C, Dommisch H, Groessner-Schreiber B, Jepsen S, Loos BG, Schreiber S: A 3 UTR transition within DEFB1 is associated with chronic and aggressive periodontitis. Genes Immun 2009;11:45-54.
48. Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, Nix MA, Kerns JA, Schmutz SM, Millhauser GL, Barsh GS: A β-defensin mutation causes black coat color in domestic dogs. Science 2007;318:1418-1423. (Pubitemid 350208947)
49. Owerbach D, Hjorth JP: Inheritance of a parotid secretory protein in mice and its use in determining salivary amylase quantitative variants. Genetics 1980;95:129-141. (Pubitemid 10012092)
50. Barsh GS, Epstein CJ: Physical and geneticcharacterization of a 75-kilobase deletion associated with al, a recessive lethal allele at the mouse agouti locus. Genetics 1989;121:811-818. (Pubitemid 19105490)
51. Thompson RC, Ohlsson K: Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A 1986; 83:6692-6696. (Pubitemid 16002300)
52. Doumas S, Kolokotronis A, Stefanopoulos P: Antiinflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect Immun 2005;73: 1271-1274. (Pubitemid 40470711)
53. Westin U, Nystrom M, Ljungcrantz I, Eriksson B, Ohlsson K: The presence of elafin, SLPI, IL1-RA and STNFalpha RI in head and neck squamous cell carcinomas and their relation to the degree of tumour differentiation. Mediators Inflamm 2002; 11:7-12. (Pubitemid 34252541)
54. McNeely TB, Dealy M, Dripps DJ, Orenstein JM, Eisenberg SP, Wahl SM: Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J Clin Invest 1995;96:456-464.
55. Tomee JF, Hiemstra PS, Heinzel-Wieland R, Kauffman HF: Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis 1997;176:740-747. (Pubitemid 27360541)
56. Shugars DC, Watkins CA, Cowen HJ: Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age. Gerontology 2001;47:246-253. (Pubitemid 32725028)
57. Lin AL, Johnson DA, Stephan KT, Yeh C-K: Salivary secretory leukocyte protease inhibitor increases in HIV infection. J Oral Pathol Med 2004;33:410-416. (Pubitemid 38988196)
58. Nakamura-Minami M, Furuichi Y, Ishikawa K, Mitsuzono-Tofuku Y, Izumi Y: Changes of alpha1-protease inhibitor and secretory leukocyte protease inhibitor levels in gingival crevicular fluid before and after non-surgical periodontal treatment. Oral Dis 2003;9:249-254. (Pubitemid 37047633)
59. Ashcroft GS, Lei K, Jin W, Longenecker G, Kulkarni AB, Greenwell-Wild T, Hale-Donze H, McGrady G, Song X-Y, Wahl SM: Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med 2000;6: 1147-1153.
60. Odaka C, Mizuochi T, Yang J, Ding A: Murine macrophages produce secretory leukocyte protease inhibitor during clearance of apoptotic cells: implications for resolution of the inflammatory response. J Immunol 2003;171:1507-1514. (Pubitemid 36900086)
61. Madsen HO, Hjorth JP: Molecular cloning of mouse PSP mRNA. Nucleic Acids Res 1985;13:1-13.
62. Mirels L, Ball WD: Neonatal rat submandibulargland protein SMG-A and parotid secretory protein are alternatively regulated members of a salivary protein multigene family. J Biol Chem 1992;267: 2679-2687.
63. Geetha C, Venkatesh SG, Fasciotto Dunn BH, Gorr S-U: Expression and anti-bacterial activity of human parotid secretory protein (PSP). Biochem Soc Trans 2003;31:815-818. (Pubitemid 36981134)
64. Geetha C, Venkatesh SG, Bingle L, Bingle CD, Gorr SU: Design and validation of anti-inflammatory peptides from human parotid secretory protein. J Dent Res 2005;84:149-153. (Pubitemid 43822047)
65. Bingle L, Barnes FA, Lunn H, Musa M, Webster S, Douglas CW, Cross SS, High AS, Bingle CD: Characterisation and expression of SPLUNC2, the human orthologue of rodent parotid secretory protein. Histochem Cell Biol 2009;132:339-349.
66. Shiba H, Venkatesh SG, Gorr SU, Barbieri G, Kurihara H, Kinane DF: Parotid secretory protein is expressed and inducible in human gingival keratinocytes. J Periodontal Res 2005;40:153-157. (Pubitemid 40417314)
67. Wu Y, Shu R, Luo LJ, Ge LH, Xie YF: Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J Periodontal Res 2009;44:636-644.
68. Bingle CD, Craven CJ: PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet 2002;11:937-943. (Pubitemid 34449781)
69. Bingle CD, Gorr S-U: Host defense in oral and airway epithelia: chromosome 20 contributes a new protein family. Int J Biochem Cell Biol 2004;36:2144-2152. (Pubitemid 39094438)
70. Robinson CP, Bounous DI, Alford CE, Nguyen KH, Nanni JM, Peck AB, Humphreys-Beher MG: PSP expression in murine lacrimal glands and function as a bacteria binding protein in exocrine secretions. Am J Physiol 1997;272:G863-G871.
71. Gorr S-U, Sotsky JB, Shelar AP, Demuth DR: Design of bacteria- agglutinating peptides derived from parotid secretory protein, a member of the bactericidal/ permeability increasing-like protein family. Peptides 2008;29:2118-2127. (Pubitemid 50326971)
72. Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, Refaeli Y, Bowler R, Wenzel SE, Chen Z, Zdunek J, Breed R, Young R, Allaire E, Martin RJ: Function and regulation of SPLUNC1 protein in mycoplasma infection and allergic inflammation. J Immunol 2007;179:3995-4002.
73. Haigh B, Hood K, Broadhurst M, Medele S, Callaghan M, Smolenski G, Dines M, Wheeler T: The bovine salivary proteins BSP30a and BSP30b are independently expressed BPI-like proteins with anti-Pseudomonas activity. Mol Immunol 2007;45: 1944-1951. (Pubitemid 351226276)
74. Ghafouri B, Kihlstrom E, Tagesson C, Lindahl M: PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta 2004;1699:57-63. (Pubitemid 38680794)
75. Abdolhosseini M, Sotsky JB, Shelar AP, Joyce PB, Gorr SU: Human parotid secretory protein is a lipopolysaccharide-binding protein: identification of an anti-inflammatory peptide domain. Mol Cell Biochem 2011;DOI 10.1007/s11010-011- 0991-2.
76. Gakhar L, Bartlett JA, Penterman J, Mizrachi D, Singh PK, Mallampalli RK, Ramaswamy S, McCray PB Jr: PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One 2010;5:e9098.
77. McDonald RE, Fleming RI, Beeley JG, Bovell DL, Lu JR, Zhao X, Cooper A, Kennedy MW: Latherin: a surfactant protein of horse sweat and saliva. PLoS ONE 2009;4:e5726.
78. Lee YH, Wong DT: Saliva: an emerging biofluid for early detection of diseases. Am J Dent 2009;22:241-248.
79. Malamud D: Saliva as a diagnostic fluid. Dental Clin N Am 2011;55:159-178.
80. Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT: Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontology 2000 2009;50:52-64.
81. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, Floriano PN, Simmons G, Bhagwandin B, Jacobson JW, Redding SW, Ebersole JL, McDevitt JT: Current developments in salivary diagnostics. Biomark Med 2010;4: 171-189.
82. Haigh BJ, Stewart KW, Whelan JR, Barnett MP, Smolenski GA, Wheeler TT: Alterations in the salivary proteome associated with periodontitis. J Clin Periodontol 2010;37:241-247.
83. Linden GJ, Mullally BH, Burden DJ, Lamey PJ, Shaw C, Ardill J, Lundy FT: Changes in vasoactive intestinal peptide in gingival crevicular fluid in response to periodontal treatment. J Clin Periodontol 2002; 29:484-489. (Pubitemid 41705016)
84. Kaner D, Bernimoulin J, Kleber B, Heizmann W, Friedmann A: Gingival crevicular fluid levels of calprotectin and myeloperoxidase during therapy for generalized aggressive periodontitis. J Periodontal Res 2006;41:132-139. (Pubitemid 43341286)
85. Lehrer RI, Ganz T: Antimicrobial polypeptides of human neutrophils. Blood 1990;76:2169-2181.
86. Lominadze G, Powell DW, Luerman GC, Link AJ, Ward RA, McLeish KR: Proteomic analysis of human neutrophil granules. Mol Cell Proteomics 2005;4:1503-1521. (Pubitemid 41555476)
87. Lundy FT, O'Hare MMT, McKibben BM, Fulton CR, Briggs JE, Linden GJ: Radioimmunoassay quantification of adrenomedullin in human gingival crevicular fluid. Arch Oral Biol 2006;51:334-338. (Pubitemid 43363509)
88. Mogi M, Otogoto J, Ota N, Inagaki H, Minami M, Kojima K: Interleukin 1[beta], interleukin 6, [beta]2-microglobulin, and transforming growth factor-[alpha] in gingival crevicular fluid from human periodontal disease. Arch Oral Biol 1999;44: 535-539. (Pubitemid 29264475)
89. Vardar-Sengul S, Demirci T, Sen BH, Erkizan V, Kurulgan E, Baylas H: Human β-defensin-1 and -2 expression in the gingiva of patients with specific periodontal diseases. J Periodontal Res 2007;42:429-437.
90. Lundy FT, Chalk R, Lamey P-J, Shaw C, Linden GJ: Quantitative analysis of MRP-8 in gingival crevicular fluid in periodontal health and disease using microbore HPLC. J Clin Periodontol 2001;28:1172-1177. (Pubitemid 33755225)
91. Henskens YM, van den Keijbus PA, Veerman EC, Van der Weijden GA, Timmerman MF, Snoek CM, Van der Velden U, Nieuw Amerongen AV: Protein composition of whole and parotid saliva in healthy and periodontitis subjects: determination of cystatins, albumin, amylase and IgA. J Periodontal Res 1996;31:57-65.
92. Friedman SA, Mandel ID, Herrera MS: Lysozyme and lactoferrin quantitation in the crevicular fluid. J Periodontol 1983;54:347-350.
93. Adonogianaki E, Mooney J, Kinane DF: The ability of gingival crevicular fluid acute phase proteins to distinguish healthy, gingivitis and periodontitis sites. J Clin Periodontol 1992;19:98-102.
94. Bissell J, Joly S, Johnson GK, Organ CC, Dawson D, McCray PB Jr, Guthmiller JM: Expression of β-defensins in gingival health and in periodontal disease. J Oral Pathol Med 2004;33:278-285. (Pubitemid 38579446)
95. Lundy FT, Shaw C, McKinnell J, Lamey PJ, Linden GJ: Calcitonin gene-related peptide in gingival crevicular fluid in periodontal health and disease. J Clin Periodontol 1999;26:212-216.
96. Ito T, Komiya-Ito A, Arataki T, Furuya Y, Yajima Y, Yamada S, Okuda K, Kato T: Relationship between antimicrobial protein levels in whole saliva and periodontitis. J Periodontol 2008;79:316-322.
97. Baron AC, Gansky SA, Ryder MI, Featherstone DB: Cysteine protease inhibitory activity and levels of salivary cystatins in whole saliva of periodontally diseased patients. J Periodontal Res 1999;34:437-444.
98. Lopatin DE, Caffesse ER, Bye FL, Caffesse RG: Concentrations of fibronectin in the sera and crevicular fluid in various stages of periodontal disease. J Clin Periodontol 1989;16:359-364.
99. Wang PL, Azuma Y, Shinohara M, Ohura K: Effect of actinobacillus actinomycetemcomitans protease on the proliferation of gingival epithelial cells. Oral Dis 2001;7:233-237. (Pubitemid 32734922)
100. Groenink J, Walgreen-Weterings E, Nazmi K, Bolscher JG, Veerman EC, van Winkelhoff AJ, Nieuw Amerongen AV: Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitansassociated periodontitis. J Clin Periodontol 1999;26: 269-275.
101. Lundy FT, El Karim IA, Linden GJ: Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease. Arch Oral Biol 2009;54:258-262.